Retroviral Genetics Laboratory, Centre for Virus Research, Westmead Millennium Institute, Westmead Hospital, The University of Sydney, New South Wales, Australia.
Virol J. 2011 Aug 16;8:405. doi: 10.1186/1743-422X-8-405.
Positive controls are an integral component of any sensitive molecular diagnostic tool, but this can be affected, if several mutations are being screened in a scenario of a pandemic or newly emerging disease where it can be difficult to acquire all the necessary positive controls from the host. This work describes the development of a synthetic oligo-cassette for positive controls for accurate and highly sensitive diagnosis of several mutations relevant to influenza virus drug resistance.
Using influenza antiviral drug resistance mutations as an example by employing the utility of synthetic paired long oligonucleotides containing complementary sequences at their 3' ends and utilizing the formation of oligonucleotide dimers and DNA polymerization, we generated ~170bp dsDNA containing several known specific neuraminidase inhibitor (NAI) resistance mutations. These templates were further cloned and successfully applied as positive controls in downstream assays.
This approach significantly improved the development of diagnosis of resistance mutations in terms of time, accuracy, efficiency and sensitivity, which are paramount to monitoring the emergence and spread of antiviral drug resistant influenza strains. Thus, this may have a significantly broader application in molecular diagnostics along with its application in rapid molecular testing of all relevant mutations in an event of pandemic.
阳性对照是任何敏感分子诊断工具的一个组成部分,但在大流行或新出现的疾病情况下,如果难以从宿主中获得所有必要的阳性对照,这可能会受到影响,此时需要对几种突变进行筛选。本研究描述了一种用于流感病毒耐药性相关几种突变的准确和高度敏感诊断的合成寡核苷酸盒的开发。
我们以流感抗病毒药物耐药性突变为例,利用含有互补序列的 3'端合成的配对长寡核苷酸的实用性,并利用寡核苷酸二聚体和 DNA 聚合的形成,生成了约 170bp 的 dsDNA,其中包含几种已知的特定神经氨酸酶抑制剂 (NAI) 耐药突变。这些模板进一步克隆,并成功地应用于下游检测作为阳性对照。
该方法在时间、准确性、效率和灵敏度方面显著改善了耐药突变的诊断开发,这对于监测抗病毒药物耐药性流感株的出现和传播至关重要。因此,除了在大流行时快速进行所有相关突变的分子检测外,它在分子诊断中可能具有更广泛的应用。